Page last updated: 2024-12-06

dita

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

DITA: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID36649
MeSH IDM0056821

Synonyms (13)

Synonym
dita
ethanone, 1-(3,4-dichlorophenyl)-2-((4,5-dihydro-1h-imidazol-2-yl)thio)-
brn 0753683
acetophenone, 3',4'-dichloro-2-(2-imidazolin-2-ylthio)-
1-(3,4-dichlorophenyl)-2-((4,5-dihydro-1h-imidazol-2-yl)thio)ethanone
3',4'-dichloro-2-(2-imidazolin-2-ylthio)acetophenone
2-(3,4-dichlorophenacylthio)-2-imidazoline
1-(3,4-dichlorophenyl)-2-(4,5-dihydro-1h-imidazol-2-ylsulfanyl)ethanone
36066-03-2
DTXSID80189645
1-(3,4-dichlorophenyl)-2-((4,5-dihydro-1h-imidazol-2-yl)thio)ethan-1-one
A924018
1-(3,4-dichlorophenyl)-2-(4,5-dihydro-1h-imidazol-2-ylsulfanyl)ethan-1-one

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 68.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index68.98 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index189.27 (26.88)
Search Engine Supply Index3.37 (0.95)

This Compound (68.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]